Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

Conference Years:

Days Within Meeting:

Session Type:

Availability:

  • Sort by:
  • Browse by:
<< first | < prev page: of 2 records per page: next > | last >>
pages: 1 2 presentations: 1 to 50 of 92 from CROI 2017
THURSDAY PLENARY SESSION
IF YOU CAN MAKE IT THERE: ENDING THE HIV EPIDEMIC IN NEW YORK
Demetre C Daskalakis
NYC Department of Health and Mental Hygiene, New York, NY, USA
from CROI 2017 on February 16, 2017 8:30 AM-9:30 AM
THURSDAY PLENARY SESSION
HTLV-1: THE OTHER HUMAN RETROVIRUS
Charles RM Bangham
Imperial College London, London, United Kingdom
from CROI 2017 on February 16, 2017 8:30 AM-9:30 AM
ORAL ABSTRACT: HEPATITIS C: PROBLEMS AND PROGRESS
INCIDENCE OF HEPATITIS C AMONG HIV-INFECTED MEN WHO HAVE SEX WITH MEN, 2000–2015
Natasha Martin
University of California San Diego, San Diego, CA, USA
from CROI 2017 on February 16, 2017 10:00 AM-12:00 PM
ORAL ABSTRACT: HEPATITIS C: PROBLEMS AND PROGRESS
MODELING HIV-HCV EPIDEMIOLOGY IN THE DAA ERA: THE ROAD TO ERADICATION
Victor Virlogeu
INSERM, LYON, France
from CROI 2017 on February 16, 2017 10:00 AM-12:00 PM
ORAL ABSTRACT: HEPATITIS C: PROBLEMS AND PROGRESS
UNRESTRICTED DAA ACCESS IN THE NETHERLANDS: RAPID THERAPY UPTAKE IN HIV+HCV+ PATIENTS
Anne Boerekamps
Erasmus MC, Rotterdam, Netherlands
from CROI 2017 on February 16, 2017 10:00 AM-12:00 PM
ORAL ABSTRACT: HEPATITIS C: PROBLEMS AND PROGRESS
SUBSTANTIAL DECLINE IN ACUTE HCV INFECTIONS AMONG DUTCH HIV+MSM AFTER DAA ROLL OUT
Bart Rijnders
Erasmus MC Rotterdam, Rotterdam, Netherlands
from CROI 2017 on February 16, 2017 10:00 AM-12:00 PM
ORAL ABSTRACT: HEPATITIS C: PROBLEMS AND PROGRESS
CORRELATION OF RENAL BIOMARKERS AND TENOFOVIR AUC IN THE ION-4 STUDY COHORT
Austin Wei-Hong Chan
Duke University, Durham, NC, USA
from CROI 2017 on February 16, 2017 10:00 AM-12:00 PM
ORAL ABSTRACT: HEPATITIS C: PROBLEMS AND PROGRESS
HEPATOCELLULAR CARCINOMA AFTER SVR WITH IFN-FREE REGIMENS IN HIV/HCV COINFECTION
Nicolás Merchante
Hospital Universitario de Valme, Sevilla, Spain
from CROI 2017 on February 16, 2017 10:00 AM-12:00 PM
ORAL ABSTRACT: HEPATITIS C: PROBLEMS AND PROGRESS
IDENTIFICATION OF HCV INTER-SUBTYPE RECOMBINANT STRAINS WITH BREAKPOINTS IN NS5A
Suqin Cai
Monogram Biosciences, South San Francisco, USA
from CROI 2017 on February 16, 2017 10:00 AM-12:00 PM
ORAL ABSTRACT: HEPATITIS C: PROBLEMS AND PROGRESS
SYNERGY BETWEEN COMBINATIONS OF ANTI-HCV BROADLY NEUTRALIZING MONOCLONAL ANTIBODIES
Madeleine Clare Percey Mankowski
Johns Hopkins University, Severna Park, MD, USA
from CROI 2017 on February 16, 2017 10:00 AM-12:00 PM
ORAL ABSTRACT: HIV PERSISTENCE AND REACTIVATION
TLR7 AGONIST GS-9620 INCREASES IMMUNE-MEDIATED CLEARANCE OF HIV-INFECTED CELLS
Jeffrey Murry
Gilead Sciences, Foster City, CA, USA
from CROI 2017 on February 16, 2017 10:00 AM-12:00 PM
ORAL ABSTRACT: HIV PERSISTENCE AND REACTIVATION
VIRAL CONTROL INDUCED BY HIVCONSV VACCINES & ROMIDEPSIN IN EARLY TREATED INDIVIDUALS
Beatriz Mothe
IrsiCaixa-HIVACAT, Hospital Germans Trias i Pujol, Badalona, Spain
from CROI 2017 on February 16, 2017 10:00 AM-12:00 PM
ORAL ABSTRACT: HIV PERSISTENCE AND REACTIVATION
NO EVIDENCE OF ONGOING HIV REPLICATION AFTER 7 YEARS ON ART
Mary F Kearney
National Cancer Institute, National Institutes of Health, Frederick, MD, USA
from CROI 2017 on February 16, 2017 10:00 AM-12:00 PM
ORAL ABSTRACT: HIV PERSISTENCE AND REACTIVATION
A PROPORTION OF LATENT HIV IS MISSED BY ASSAYING ONLY RESTING CD4 T CELLS
Michele Sobolewski
University of Pittsburgh, Pittsburgh, PA, USA
from CROI 2017 on February 16, 2017 10:00 AM-12:00 PM
ORAL ABSTRACT: HIV PERSISTENCE AND REACTIVATION
CTLS PARE DEFECTIVE HIV PROVIRUSES WITHOUT IMPACTING INFECTIOUS LATENT RESERVOIRS
Szuhan Huang
George Washington University, Washington , DC, USA
from CROI 2017 on February 16, 2017 10:00 AM-12:00 PM
ORAL ABSTRACT: HIV PERSISTENCE AND REACTIVATION
DEVELOPMENT OF A PKC AGONIST DERIVED FROM INGENOL FOR HIV LATENCY DISRUPTION IN VIVO
Jessica Brehm
GlaxoSmithKline, Durham, NC, USA
from CROI 2017 on February 16, 2017 10:00 AM-12:00 PM
ORAL ABSTRACT: HIV PERSISTENCE AND REACTIVATION
HIV RNA REBOUND POSTINTERRUPTION IN PERSONS SUPPRESSED IN FIEBIG I ACUTE HIV
Jintanat Ananworanich
US Military HIV Research Program, Thai Red Cross, Bethesda, MD, USA
from CROI 2017 on February 16, 2017 10:00 AM-12:00 PM
ORAL ABSTRACT: HIV PERSISTENCE AND REACTIVATION
EARLY DETECTION OF HIV REBOUND BY INNATE SENSORS POST ART INTERRUPTION
Julie Mitchell
U.S. Military HIV Research Program, Silver Spring, MD, USA
from CROI 2017 on February 16, 2017 10:00 AM-12:00 PM
ORAL ABSTRACT: IMPROVING THE HIV CARE CASCADE
A COMBINATION INTERVENTION STRATEGY FOR HIV LINKAGE AND RETENTION IN MOZAMBIQUE
Matthew R Lamb
Columbia University, New York, NY, USA
from CROI 2017 on February 16, 2017 10:00 AM-12:00 PM
ORAL ABSTRACT: IMPROVING THE HIV CARE CASCADE
PEER NAVIGATION ENHANCES HIV CARE RETENTION: AN RCT IN SOUTH AFRICAN PRIMARY CLINICS
Wayne T. Steward
University of California, San Francisco, San Francisco, CA, USA
from CROI 2017 on February 16, 2017 10:00 AM-12:00 PM
ORAL ABSTRACT: IMPROVING THE HIV CARE CASCADE
COST-EFFECTIVENESS OF POLICY OPTIONS WHEN PRETREATMENT NNRTI DRUG RESISTANCE IS HIGH
Andrew Phillips
University College London, London, United Kingdom
from CROI 2017 on February 16, 2017 10:00 AM-12:00 PM
ORAL ABSTRACT: IMPROVING THE HIV CARE CASCADE
INCREASED RISK OF CART FAILURE AFTER LOW-LEVEL VIREMIA UNDER WHO GUIDELINES
Lucas Etienne Hermans
University Medical Center Utrecht, Groblersdal, South Africa
from CROI 2017 on February 16, 2017 10:00 AM-12:00 PM
ORAL ABSTRACT: IMPROVING THE HIV CARE CASCADE
REAL PROGRESS IN THE HIV EPIDEMIC: PHIA FINDINGS FROM ZIMBABWE, MALAWI, AND ZAMBIA
Jessica E Justman
ICAP at Columbia University, Mailman School of Public Health, New York, USA, NewYork, NY, USA
from CROI 2017 on February 16, 2017 10:00 AM-12:00 PM
ORAL ABSTRACT: IMPROVING THE HIV CARE CASCADE
STRATEGIES TO ACHIEVE 90-90-90: MODELING INSIGHTS FROM ZIMBABWE
Jack Olney
Imperial College London, London, London, United Kingdom
from CROI 2017 on February 16, 2017 10:00 AM-12:00 PM
ORAL ABSTRACT: IMPROVING THE HIV CARE CASCADE
HIV CASCADE OF CARE INTERVENTIONS IN KENYA: CLINICAL IMPACT AND COST-EFFECTIVENESS
Liem Binh Luong Nguyen
INSERM, Paris, France
from CROI 2017 on February 16, 2017 10:00 AM-12:00 PM
ORAL ABSTRACT: IMPROVING THE HIV CARE CASCADE
A RANDOMIZED TRIAL OF READY-TO-USE SUPPLEMENTARY FOOD AT ART INITIATION IN AFRICA
Jane Edith Mallewa
College of Medicine, University of Malawi, Blantyre, Malawi
from CROI 2017 on February 16, 2017 10:00 AM-12:00 PM
ORAL ABSTRACT: INFLAMMATION AND AGE-RELATED COMPLICATIONS
IL-1β INHIBITION SIGNIFICANTLY REDUCES ATHEROSCLEROTIC INFLAMMATION IN TREATED HIV
Priscilla Hsue
University of California, San Francisco, San Francisco, CA, USA
from CROI 2017 on February 16, 2017 10:00 AM-12:00 PM
ORAL ABSTRACT: INFLAMMATION AND AGE-RELATED COMPLICATIONS
HYPERBILIRUBINEMIA PREVENTS CARDIOVASCULAR DISEASE FOR HIV+ AND HIV- INDIVIDUALS
Vincent C. Marconi
School of Medicine, Emory University, Atlanta, GA, USA
from CROI 2017 on February 16, 2017 10:00 AM-12:00 PM
ORAL ABSTRACT: INFLAMMATION AND AGE-RELATED COMPLICATIONS
ASSOCIATION BETWEEN CARDIOVASCULAR DISEASE & CONTEMPORARILY USED PROTEASE INHIBITORS
Lene Ryom
CHIP, Department of Infectious Diseases, Copenhagen, Denmark
from CROI 2017 on February 16, 2017 10:00 AM-12:00 PM
ORAL ABSTRACT: INFLAMMATION AND AGE-RELATED COMPLICATIONS
CARDIOVASCULAR PREVENTION POLICY IN HIV: RECOMMENDATIONS FROM A MODELING STUDY
Rosan van Zoest
Amsterdam Institute for Global Health and Development, Amsterdam, Netherlands
from CROI 2017 on February 16, 2017 10:00 AM-12:00 PM
ORAL ABSTRACT: INFLAMMATION AND AGE-RELATED COMPLICATIONS
IMPACT OF SMOKING, HYPERTENSION & CHOLESTEROL ON MYOCARDIAL INFARCTION IN HIV+ ADULTS
Keri N Althoff
Johns Hopkins University, Baltimore, MD, USA
from CROI 2017 on February 16, 2017 10:00 AM-12:00 PM
ORAL ABSTRACT: INFLAMMATION AND AGE-RELATED COMPLICATIONS
CESSATION OF CIGARETTE SMOKING AND THE IMPACT ON CANCER INCIDENCE IN THE D:A:D STUDY
Leah Shepherd
University College London, London, United Kingdom
from CROI 2017 on February 16, 2017 10:00 AM-12:00 PM
ORAL ABSTRACT: INFLAMMATION AND AGE-RELATED COMPLICATIONS
BONE DENSITY AND TRABECULAR BONE SCORE IMPROVE FRACTURE PREDICTION IN HIV+ WOMEN
Jingyan Yang
Columbia University, New York, NY, USA
from CROI 2017 on February 16, 2017 10:00 AM-12:00 PM
ORAL ABSTRACT: INFLAMMATION AND AGE-RELATED COMPLICATIONS
FRAILTY PROGRESSION AND RECOVERY AMONG PERSONS AGING WITH HIV AND SUBSTANCE USE
Damani A Piggott
Johns Hopkins University, Baltimore, MD, USA
from CROI 2017 on February 16, 2017 10:00 AM-12:00 PM
THURSDAY PRESS CONFERENCE
DISCUSSION OF ORAL ABSTRACT SESSION 9 – HEPATITIS C: PROBLEMS AND PROGRESS
CHAIR
David Thomas
Johns Hopkins School of Medicine, Baltimore, MD, USA
OA9: MODELING HIV-HCV EPIDEMIOLOGY IN THE DAA ERA: THE ROAD TO ERADICATION
Victor Virlogeux
INSERM, Lyon, France
OA9: SUBSTANTIAL DECLINE IN ACUTE HCV INFECTIONS AMONG DUTCH HIV+ MSM AFTER DAA ROLL OUT
Bart Rijnders
Erasmus Univ Med Cntr, Rotterdam, Netherlands
from CROI 2017 on February 16, 2017 12:15 PM-1:15 PM
THURSDAY PRESS CONFERENCE
DISCUSSION OF ORAL ABSTRACT SESSION 12 – INFLAMATION AND AGE-RELATED COMPLICATIONS
CHAIR
Peter Hunt
University of California, San Francisco, CA, USA
OA12: IL-1&BETA; INHIBITION SIGNIFICANTLY REDUCES ATHEROSCLEROTIC INFLAMMATION IN TREATED HIV
Priscilla Hsue
Univ of California San Francisco, San Francisco, CA, USA
OA12: ASSOCIATION BETWEEN CARDIOVASCULAR DISEASE & CONTEMPORARILY USED PROTEASE INHIBITORS
Lene Ryom
CHIP, Copenhagen, Denmark
OA12: CESSATION OF CIGARETTE SMOKING AND THE IMPACT ON CANCER INCIDENCE IN THE D:A:D STUDY
Leah Shepherd
Univ Coll London, London, UK
from CROI 2017 on February 16, 2017 12:15 PM-1:15 PM
THURSDAY PRESS CONFERENCE
DISCUSSION OF ORAL ABSTRACT SESSION 11 – HIV PERSISTENCE AND REACTIVATION AND POSTER SESSION 4 – HIV PERSISTENCE: SEND IN THE CLONES
CHAIR
Peter Hunt
University of California, San Francisco, CA, USA
OA11: VIRAL CONTROL INDUCED BY HIVCONSV VACCINES & ROMIDEPSIN IN EARLY TREATED INDIVIDUALS
Beatriz Mothe
IrsiCaixa AIDS Rsr Inst, Badalona, Spain
OA11: NO EVIDENCE OF ONGOING HIV REPLICATION AFTER 7 YEARS ON ART
Mary Kearney
NCI, Frederick, MD, USA
PS4: RESURGENCE OF HIV-1 FOUNDER VIRUSES FOLLOWING ANTIRETROVIRAL TREATMENT INTERRUPTION
Morgane Rolland
US Military HIV Rsr Prog, Silver Spring, MD, USA
from CROI 2017 on February 16, 2017 12:15 PM-1:15 PM
THEMED DISCUSSION: EMERGING VIRUSES: THE ZIKA VIRUS
THEMED DISCUSSION LEADER
Robert T Schooley
University of California San Diego, La Jolla, CA, USA
from CROI 2017 on February 16, 2017 1:30 PM-2:30 PM
THEMED DISCUSSION: EMERGING VIRUSES: THE ZIKA VIRUS
CHARACTERIZATION OF MORE THAN 10,000 ZIKA VIRUS TEST RESULTS IN THE US
Joseph M Volpe
LabCorp, Durham, NC, USA
from CROI 2017 on February 16, 2017 1:30 PM-2:30 PM
THEMED DISCUSSION: EMERGING VIRUSES: THE ZIKA VIRUS
ZIKA VIRUS PERSISTENCE IN BODY FLUIDS
Gabriela Paz-Bailey
Centers for Disease Control and Prevention, Atlanta, USA
from CROI 2017 on February 16, 2017 1:30 PM-2:30 PM
THEMED DISCUSSION: EMERGING VIRUSES: THE ZIKA VIRUS
NEUROLOGIC CONSEQUENCES OF POSTNATAL ZIKA VIRUS INFECTION IN INFANTS
Maud Mavigner
Emory University School of Medicine, Atlanta, GA, USA
from CROI 2017 on February 16, 2017 1:30 PM-2:30 PM
THEMED DISCUSSION: EMERGING VIRUSES: THE ZIKA VIRUS
ZIKA VIRUS PROTECTION BY A SINGLE LOW-DOSE NUCLEOSIDE-MODIFIED MRNA VACCINATION
Michael J Hogan
University of Pennsylvania, Philadelphia, PA, USA
from CROI 2017 on February 16, 2017 1:30 PM-2:30 PM
THEMED DISCUSSION: EMERGING VIRUSES: THE ZIKA VIRUS
QUESTIONS AND ANSWERS
from CROI 2017 on February 16, 2017 1:30 PM-2:30 PM
THEMED DISCUSSION: HIV AND SUBSTANCE ABUSE: DOUBLE TROUBLE
THEMED DISCUSSION LEADER
Steven Shoptaw
University of California Los Angeles, Los Angeles, CA, USA
from CROI 2017 on February 16, 2017 1:30 PM-2:30 PM
THEMED DISCUSSION: HIV AND SUBSTANCE ABUSE: DOUBLE TROUBLE
'HOOKED ON PAINKILLERS' PRIOR TO FIRST INJECTION AMONG PWID IN 16 U.S. CITIES
Dita Broz
Centers for Disease Control and Prevention, Atlanta, USA
from CROI 2017 on February 16, 2017 1:30 PM-2:30 PM
THEMED DISCUSSION: HIV AND SUBSTANCE ABUSE: DOUBLE TROUBLE
OPIOID SUBSTITUTION THERAPY AND INITIATION INTO INJECTION DRUG USE IN SAN DIEGO, CA
Maria Luisa Mittal
University of California San Diego, La Jolla, CA, USA
from CROI 2017 on February 16, 2017 1:30 PM-2:30 PM
THEMED DISCUSSION: HIV AND SUBSTANCE ABUSE: DOUBLE TROUBLE
CHANGES IN PRESCRIPTION OPIOID, METH, AND COCAINE USE AMONG MSM IN 20 US CITIES
Brooke Hoots
Centers for Disease Control and Prevention, Atlanta, GA, USA
from CROI 2017 on February 16, 2017 1:30 PM-2:30 PM
THEMED DISCUSSION: HIV AND SUBSTANCE ABUSE: DOUBLE TROUBLE
CHANGING PATTERN OF CRYSTAL METH USE IN BLACK & WHITE MSM, WASHINGTON, DC, 2008–2014
Irene Kuo
George Washington University Milken Institute School of Public Health, Washington, DC, USA
from CROI 2017 on February 16, 2017 1:30 PM-2:30 PM
THEMED DISCUSSION: HIV AND SUBSTANCE ABUSE: DOUBLE TROUBLE
INCREASING METHAMPHETAMINE USE AMONG NON-MSM WHO INJECT DRUGS IN KING COUNTY, WA
Sara Nelson Glick
University of Washington, Seattle, WA, USA
from CROI 2017 on February 16, 2017 1:30 PM-2:30 PM
THEMED DISCUSSION: HIV AND SUBSTANCE ABUSE: DOUBLE TROUBLE
QUESTIONS AND ANSWERS
from CROI 2017 on February 16, 2017 1:30 PM-2:30 PM
<< first | < prev page: of 2 records per page: next > | last >>
pages: 1 2 presentations: 1 to 50 of 92 from CROI 2017